{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.190","meta":{"versionId":"6","lastUpdated":"2021-07-20T01:02:12.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.190","version":"20210720","name":"Polatuzumab Vedotin Injectable","status":"active","date":"2021-07-20T01:02:12-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"2174095","display":"polatuzumab vedotin-piiq 140 MG Injection"},{"code":"2398131","display":"polatuzumab vedotin-piiq 30 MG Injection"}]}]},"expansion":{"identifier":"urn:uuid:57007217-5fa9-4c02-8527-42c25efbb611","timestamp":"2022-06-10T10:58:57-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"2174095","display":"polatuzumab vedotin-piiq 140 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"2398131","display":"polatuzumab vedotin-piiq 30 MG Injection"}]}}